Quality of life improves with treatment in the Canadian trial of Atrial Fibrillation

American Heart Journal

Volumn 143, Issue 6, 2002, Pages 984-990

  Dorian, Paul ^a   Paquette, Miney ^a   Newman, David ^a   Green, Martin ^b   Connolly, Stuart J ^c   Talajic, Mario ^d   Roy, Denis ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DISOPYRAMIDE; FLECAINIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ADULT; AGED; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SELF REPORT; SYMPTOMATOLOGY; WELLBEING;

EID: 0036088496     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.122518     Document Type: Article

References (24)

1. Epidemiologic features of chronic atrial fibrillation: The Framingham study
2. Characteristics and prognosis of lone atrial fibrillation: 30-Year follow-up in the Framingham Study
3. Impact of atrial fibrillation on mortality, stroke and medical costs
4. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: Impact of treatment in paroxysmal and established atrial fibrillation
5. The impairment of heolth-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy
6. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation
7. Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia
8. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance
9. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials
10. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
11. Pilot study and protocol of the Canadian Trial of Atrial Fibrillation (CTAF)
12. Amiodarone to prevent recurrence of atrial fibrillation
13. The MOS 36-Item Short-Form Health Survey (SF-36), I: Conceptual framework and item selection
14. A brief self-administered questionnaire to determine functional capacity (Duke Activity Status Index)
15. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias
16. Measuring quality of life and symptom severity in patients with atrial fibrillation
17. Comparison of quality of life among patients with various cardiovascular disease (CVD)
18. Sinus rhythm at the time of assessment is associated with better quality of life than atrial fibrillation or flutter: Results from the Canadian Trial of Atrial Fibrillation
19. Impact of atrial fibrillation on quality of life: A prospective, multicenter study
20. Asymptomatic arrhythmias in patients with symptomatic atrial fibrillation and paroxysmal supraventricular tachycardia
21. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: A randomized controlled study
22. Effects of the maze operation on health-related quality of life in patients with atrial fibrillation
23. The Canadian Registry of Atrial Fibrillation: A noninterventional follow-up of patients after the first diagnosis of atrial fibrillation